Home » EUROCOR GMBH RECEIVES CE MARK APPROVAL FOR TAXCOR I
EUROCOR GMBH RECEIVES CE MARK APPROVAL FOR TAXCOR I
Eurocor Gmbh an Opto Circuits company has received CE mark approval of its new polymer-free, TAXCOR I.Paclitaxel-eluting coronary stent system. Though polymer-free, this innovative
drug-eluting stent technology eliminates any polymer-related, late adverse effect
potential for the patient, like subacute thrombosis.
My
Iris
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May